Due to its potentially beneficial anticancer properties, luteolin suppresses the K-Ras/NF-κB/GSK-3β signaling pathway, causing pancreatic cancer cells to undergo apoptosis in vivo. Here, NFKB1 is linked to familial pancreatic carcinoma.